Kuros Biosciences AG (SWX:KURN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
26.04
-0.48 (-1.81%)
Feb 20, 2026, 5:31 PM CET

Revenue by Segment

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Medical Devices
75.56M33.56M13.27M8.34M4.04M
Medical Devices Growth
125.11%153.03%59.03%106.51%-
Legacy Portfolio
--4.72M5.47M-
Legacy Portfolio Growth
---13.76%--
Total
75.56M33.56M17.99M13.82M4.04M
Total Growth
125.11%86.61%30.19%242.04%57.71%

Revenue by Geography

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States of America
72.84M32.84M17.38M13.22M3.95M
United States of America Growth
121.80%88.93%31.54%234.90%60.34%
European Union
746.00K580.00K429.00K281.00K27.00K
European Union Growth
28.62%35.20%52.67%940.74%-
Other
1.97M143.00K174.00K319.00K66.00K
Other Growth
1277.62%-17.82%-45.45%383.33%200.00%
Total
75.56M33.56M17.99M13.82M4.04M
Total Growth
125.11%86.61%30.19%242.04%57.71%
Source: S&P Global Market Intelligence.